Johnson & Johnson Trading Volume Plummets 52.81% Ranking 48th Amid Talc Controversy

On March 24, 2025, Johnson's trading volume was 13.15 billion, a significant decrease of 52.81% from the previous day, ranking 48th in the day's stock market. Johnson & Johnson (JNJ) closed the day with a 0.21% decline.

Johnson & Johnson has been facing scrutiny over its talc-based products, with a recent court ruling ordering the company to pay $2.1 billion in damages to 22 women who claimed that the company's talc products caused their ovarian cancer. This ruling has raised concerns among investors about the potential financial impact on the company.

In response to the court ruling, Johnson & Johnson has stated that it will appeal the decision and continues to maintain that its talc products are safe and do not cause cancer. The company has also announced that it will discontinue the sale of its talc-based baby powder in the United States and Canada, replacing it with a cornstarch-based alternative.

Despite the recent setbacks, Johnson & Johnson remains one of the largest and most diversified healthcare companies in the world, with a strong portfolio of products and a history of innovation. The company's stock has been relatively stable in recent months, and many analysts believe that it will continue to be a strong performer in the healthcare sector.